Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Pre-Eclampsia | 45 | 2024 | 1230 | 5.350 |
Why?
|
Phthalic Acids | 34 | 2023 | 475 | 4.870 |
Why?
|
Maternal Exposure | 37 | 2024 | 1043 | 4.660 |
Why?
|
Premature Birth | 40 | 2023 | 1771 | 3.870 |
Why?
|
Environmental Pollutants | 33 | 2024 | 1260 | 3.830 |
Why?
|
Pregnancy | 218 | 2024 | 29725 | 3.100 |
Why?
|
Pregnancy Complications | 36 | 2024 | 2940 | 3.010 |
Why?
|
Fetal Development | 15 | 2024 | 765 | 2.660 |
Why?
|
Vascular Endothelial Growth Factor Receptor-1 | 14 | 2023 | 558 | 2.600 |
Why?
|
Phenols | 22 | 2024 | 513 | 2.460 |
Why?
|
Pregnancy Trimester, First | 24 | 2024 | 909 | 2.460 |
Why?
|
Fetal Growth Retardation | 15 | 2023 | 579 | 1.980 |
Why?
|
Pregnancy Trimester, Second | 15 | 2024 | 732 | 1.920 |
Why?
|
Obstetric Labor, Premature | 11 | 2020 | 274 | 1.870 |
Why?
|
Gestational Age | 45 | 2024 | 3564 | 1.750 |
Why?
|
Pregnancy Trimesters | 5 | 2019 | 197 | 1.730 |
Why?
|
Pregnancy Proteins | 8 | 2015 | 222 | 1.710 |
Why?
|
Birth Weight | 25 | 2024 | 2094 | 1.690 |
Why?
|
Cell-Derived Microparticles | 3 | 2020 | 161 | 1.680 |
Why?
|
Dinoprost | 10 | 2024 | 138 | 1.570 |
Why?
|
Fetal Membranes, Premature Rupture | 7 | 2023 | 137 | 1.570 |
Why?
|
Pregnancy Trimester, Third | 15 | 2023 | 582 | 1.320 |
Why?
|
Oxidative Stress | 17 | 2024 | 3107 | 1.190 |
Why?
|
Infant, Newborn | 89 | 2024 | 26168 | 1.190 |
Why?
|
Pregnancy Outcome | 27 | 2023 | 2906 | 1.090 |
Why?
|
Infant, Premature | 19 | 2019 | 2091 | 1.060 |
Why?
|
Anticonvulsants | 7 | 2022 | 1881 | 1.040 |
Why?
|
Benzhydryl Compounds | 10 | 2018 | 942 | 1.010 |
Why?
|
Placenta | 19 | 2023 | 1701 | 0.980 |
Why?
|
Endocrine Disruptors | 10 | 2024 | 263 | 0.970 |
Why?
|
Delivery, Obstetric | 13 | 2022 | 933 | 0.960 |
Why?
|
Maternal-Fetal Exchange | 4 | 2021 | 463 | 0.950 |
Why?
|
Glucose Intolerance | 4 | 2022 | 579 | 0.910 |
Why?
|
Eclampsia | 2 | 2022 | 56 | 0.900 |
Why?
|
Infant, Premature, Diseases | 7 | 2014 | 708 | 0.870 |
Why?
|
Nifedipine | 1 | 2023 | 221 | 0.870 |
Why?
|
Diabetes, Gestational | 9 | 2022 | 1241 | 0.860 |
Why?
|
Female | 223 | 2024 | 391011 | 0.850 |
Why?
|
Fetal Macrosomia | 4 | 2022 | 131 | 0.850 |
Why?
|
Cervix Uteri | 5 | 2020 | 585 | 0.840 |
Why?
|
Deoxyguanosine | 5 | 2018 | 92 | 0.820 |
Why?
|
Case-Control Studies | 44 | 2023 | 22041 | 0.810 |
Why?
|
Environmental Exposure | 12 | 2024 | 4404 | 0.760 |
Why?
|
Placenta Previa | 1 | 2023 | 122 | 0.750 |
Why?
|
Epilepsy | 8 | 2022 | 3267 | 0.750 |
Why?
|
Infant, Small for Gestational Age | 8 | 2022 | 460 | 0.750 |
Why?
|
Adult | 138 | 2024 | 219847 | 0.710 |
Why?
|
Phenol | 3 | 2023 | 44 | 0.700 |
Why?
|
Amniotic Fluid | 6 | 2012 | 378 | 0.700 |
Why?
|
Cesarean Section | 8 | 2022 | 1386 | 0.690 |
Why?
|
Pregnancy Complications, Infectious | 5 | 2021 | 2127 | 0.680 |
Why?
|
Vitamin D | 12 | 2023 | 3293 | 0.670 |
Why?
|
Thyroid Hormones | 5 | 2024 | 403 | 0.660 |
Why?
|
Placenta Accreta | 1 | 2023 | 237 | 0.650 |
Why?
|
Postpartum Period | 5 | 2024 | 1168 | 0.620 |
Why?
|
Fluorocarbons | 4 | 2024 | 483 | 0.590 |
Why?
|
Plasticizers | 4 | 2024 | 50 | 0.590 |
Why?
|
Humans | 228 | 2024 | 760261 | 0.590 |
Why?
|
Cerclage, Cervical | 4 | 2020 | 39 | 0.570 |
Why?
|
Cervical Length Measurement | 1 | 2016 | 45 | 0.540 |
Why?
|
Pregnancy-Associated Plasma Protein-A | 2 | 2014 | 60 | 0.530 |
Why?
|
Vitamin D Deficiency | 6 | 2021 | 1381 | 0.530 |
Why?
|
Inflammation | 12 | 2024 | 10757 | 0.520 |
Why?
|
Body Mass Index | 16 | 2020 | 12901 | 0.520 |
Why?
|
Weight Gain | 5 | 2023 | 2347 | 0.520 |
Why?
|
Reproductive Techniques, Assisted | 2 | 2018 | 498 | 0.510 |
Why?
|
Young Adult | 56 | 2024 | 58673 | 0.510 |
Why?
|
Thyroid Diseases | 2 | 2018 | 386 | 0.500 |
Why?
|
Prenatal Exposure Delayed Effects | 8 | 2024 | 2494 | 0.500 |
Why?
|
Vitamins | 6 | 2023 | 1635 | 0.500 |
Why?
|
Respiratory Distress Syndrome, Newborn | 3 | 2006 | 227 | 0.480 |
Why?
|
Metals | 4 | 2019 | 736 | 0.480 |
Why?
|
Cytokines | 9 | 2019 | 7345 | 0.480 |
Why?
|
Twins | 2 | 2010 | 339 | 0.480 |
Why?
|
Episiotomy | 3 | 2011 | 20 | 0.470 |
Why?
|
Flame Retardants | 3 | 2024 | 93 | 0.470 |
Why?
|
Matrix Metalloproteinases | 4 | 2017 | 392 | 0.470 |
Why?
|
Maternal Age | 7 | 2020 | 807 | 0.450 |
Why?
|
Piracetam | 1 | 2014 | 88 | 0.450 |
Why?
|
Uterine Cervical Incompetence | 2 | 2010 | 29 | 0.450 |
Why?
|
Angiogenesis Inducing Agents | 2 | 2012 | 279 | 0.440 |
Why?
|
Prospective Studies | 36 | 2024 | 54263 | 0.440 |
Why?
|
Psychoses, Substance-Induced | 1 | 2014 | 99 | 0.440 |
Why?
|
Ultrasonography, Prenatal | 8 | 2022 | 1745 | 0.440 |
Why?
|
Fetal Viability | 2 | 2004 | 23 | 0.440 |
Why?
|
Prenatal Nutritional Physiological Phenomena | 1 | 2014 | 159 | 0.440 |
Why?
|
Logistic Models | 23 | 2021 | 13311 | 0.430 |
Why?
|
Obstetric Labor Complications | 5 | 2019 | 236 | 0.430 |
Why?
|
Chorioamnionitis | 4 | 2011 | 156 | 0.430 |
Why?
|
Hysterectomy | 2 | 2018 | 901 | 0.420 |
Why?
|
Blood Glucose | 7 | 2024 | 6375 | 0.420 |
Why?
|
Oxylipins | 2 | 2024 | 52 | 0.420 |
Why?
|
Obesity | 13 | 2024 | 12915 | 0.410 |
Why?
|
Boston | 20 | 2024 | 9282 | 0.400 |
Why?
|
Estrogens, Non-Steroidal | 1 | 2012 | 52 | 0.400 |
Why?
|
RNA | 1 | 2022 | 2721 | 0.390 |
Why?
|
Magnesium Sulfate | 2 | 2020 | 73 | 0.390 |
Why?
|
Pregnant Women | 7 | 2023 | 563 | 0.380 |
Why?
|
Odds Ratio | 18 | 2022 | 9712 | 0.380 |
Why?
|
Thyroid Gland | 1 | 2018 | 1169 | 0.380 |
Why?
|
Dystocia | 1 | 2011 | 33 | 0.370 |
Why?
|
Interleukin-10 | 1 | 2016 | 1174 | 0.370 |
Why?
|
Bronchopulmonary Dysplasia | 2 | 2016 | 314 | 0.360 |
Why?
|
Linear Models | 10 | 2022 | 5876 | 0.350 |
Why?
|
Pregnancy, Multiple | 2 | 2010 | 215 | 0.350 |
Why?
|
Chemokines | 4 | 2020 | 962 | 0.340 |
Why?
|
Hypertension | 5 | 2023 | 8595 | 0.340 |
Why?
|
Birth Injuries | 1 | 2011 | 150 | 0.330 |
Why?
|
Brachial Plexus | 1 | 2011 | 166 | 0.330 |
Why?
|
Microcephaly | 2 | 2010 | 423 | 0.330 |
Why?
|
Infant Mortality | 6 | 2019 | 756 | 0.330 |
Why?
|
Urinary Tract Infections | 1 | 2015 | 817 | 0.320 |
Why?
|
Placenta Diseases | 3 | 2012 | 196 | 0.320 |
Why?
|
Birth Order | 2 | 2019 | 95 | 0.320 |
Why?
|
Hypertension, Pregnancy-Induced | 4 | 2016 | 517 | 0.310 |
Why?
|
Cerebral Palsy | 2 | 2012 | 471 | 0.310 |
Why?
|
Inflammation Mediators | 3 | 2019 | 1882 | 0.310 |
Why?
|
Abnormalities, Drug-Induced | 3 | 2019 | 338 | 0.310 |
Why?
|
Eicosanoids | 2 | 2020 | 278 | 0.310 |
Why?
|
Leukomalacia, Periventricular | 1 | 2009 | 184 | 0.300 |
Why?
|
Systemic Inflammatory Response Syndrome | 1 | 2013 | 621 | 0.300 |
Why?
|
Progesterone | 2 | 2023 | 742 | 0.290 |
Why?
|
Proteinuria | 1 | 2010 | 594 | 0.290 |
Why?
|
Risk Factors | 36 | 2024 | 74269 | 0.290 |
Why?
|
Mass Spectrometry | 3 | 2020 | 2192 | 0.280 |
Why?
|
Puerperal Disorders | 2 | 2022 | 300 | 0.280 |
Why?
|
Cohort Studies | 34 | 2024 | 41317 | 0.280 |
Why?
|
Multiple Sclerosis | 5 | 2022 | 3202 | 0.280 |
Why?
|
Sensitivity and Specificity | 9 | 2022 | 14656 | 0.270 |
Why?
|
Infant, Newborn, Diseases | 2 | 2022 | 592 | 0.270 |
Why?
|
Asthma | 6 | 2023 | 6167 | 0.270 |
Why?
|
Cell Adhesion Molecules | 3 | 2011 | 1602 | 0.270 |
Why?
|
Interleukin-6 | 1 | 2016 | 3207 | 0.270 |
Why?
|
Parabens | 4 | 2019 | 114 | 0.260 |
Why?
|
Abortion, Spontaneous | 3 | 2019 | 530 | 0.260 |
Why?
|
Glucose Tolerance Test | 5 | 2024 | 1174 | 0.260 |
Why?
|
Dietary Supplements | 4 | 2024 | 3389 | 0.250 |
Why?
|
Neovascularization, Physiologic | 4 | 2019 | 1335 | 0.250 |
Why?
|
Multivariate Analysis | 8 | 2019 | 12156 | 0.240 |
Why?
|
Creatinine | 1 | 2010 | 1906 | 0.240 |
Why?
|
Fetal Organ Maturity | 2 | 2004 | 83 | 0.240 |
Why?
|
F2-Isoprostanes | 1 | 2024 | 35 | 0.230 |
Why?
|
Fetus | 5 | 2023 | 1859 | 0.230 |
Why?
|
Alkanesulfonic Acids | 2 | 2024 | 199 | 0.230 |
Why?
|
Models, Theoretical | 1 | 2016 | 3561 | 0.220 |
Why?
|
Chromatography, Liquid | 2 | 2019 | 987 | 0.220 |
Why?
|
Pulmonary Surfactants | 1 | 2004 | 161 | 0.220 |
Why?
|
Alanine Transaminase | 2 | 2016 | 607 | 0.220 |
Why?
|
Rh-Hr Blood-Group System | 1 | 2023 | 65 | 0.220 |
Why?
|
Tocolytic Agents | 1 | 2003 | 24 | 0.220 |
Why?
|
Head | 3 | 2017 | 922 | 0.210 |
Why?
|
Trophoblasts | 2 | 2018 | 224 | 0.210 |
Why?
|
Perineum | 3 | 2017 | 209 | 0.210 |
Why?
|
Estradiol | 3 | 2020 | 1932 | 0.210 |
Why?
|
Metabolome | 2 | 2020 | 976 | 0.210 |
Why?
|
Parity | 6 | 2016 | 925 | 0.200 |
Why?
|
Blood Proteins | 3 | 2013 | 1172 | 0.200 |
Why?
|
Depression | 2 | 2019 | 8033 | 0.200 |
Why?
|
Blood Group Antigens | 1 | 2023 | 187 | 0.200 |
Why?
|
Prenatal Care | 4 | 2023 | 1128 | 0.200 |
Why?
|
Environmental Monitoring | 5 | 2019 | 1441 | 0.200 |
Why?
|
Perinatology | 1 | 2002 | 62 | 0.200 |
Why?
|
Enalapril | 1 | 2023 | 313 | 0.190 |
Why?
|
Insulin-Like Growth Factor II | 2 | 2014 | 268 | 0.190 |
Why?
|
ROC Curve | 3 | 2016 | 3568 | 0.190 |
Why?
|
Albumins | 1 | 2004 | 577 | 0.190 |
Why?
|
Micronutrients | 1 | 2024 | 380 | 0.180 |
Why?
|
Obstetric Surgical Procedures | 1 | 2000 | 30 | 0.180 |
Why?
|
Infant, Extremely Low Birth Weight | 2 | 2012 | 83 | 0.180 |
Why?
|
Models, Statistical | 4 | 2019 | 5073 | 0.180 |
Why?
|
Consumer Product Safety | 1 | 2021 | 123 | 0.180 |
Why?
|
Trace Elements | 2 | 2019 | 196 | 0.180 |
Why?
|
Thyroxine | 3 | 2018 | 667 | 0.170 |
Why?
|
Cosmetics | 1 | 2021 | 102 | 0.170 |
Why?
|
Fetal Blood | 6 | 2023 | 1343 | 0.170 |
Why?
|
Chromatography, High Pressure Liquid | 2 | 2016 | 1549 | 0.170 |
Why?
|
Infertility, Female | 2 | 2013 | 760 | 0.170 |
Why?
|
Acidosis | 1 | 2021 | 271 | 0.170 |
Why?
|
Male | 45 | 2024 | 359413 | 0.170 |
Why?
|
Hydatidiform Mole | 1 | 2022 | 255 | 0.170 |
Why?
|
Analgesia, Epidural | 2 | 2019 | 330 | 0.170 |
Why?
|
United States | 20 | 2024 | 72363 | 0.170 |
Why?
|
Placentation | 1 | 2019 | 78 | 0.170 |
Why?
|
Alpha-Globulins | 1 | 2019 | 26 | 0.160 |
Why?
|
Proteinase Inhibitory Proteins, Secretory | 1 | 2019 | 48 | 0.160 |
Why?
|
Paternal Exposure | 1 | 2019 | 94 | 0.160 |
Why?
|
Factor XIII | 1 | 2019 | 59 | 0.160 |
Why?
|
Phosphatidylcholine-Sterol O-Acyltransferase | 1 | 2019 | 33 | 0.160 |
Why?
|
Laparoscopy | 3 | 2020 | 2155 | 0.160 |
Why?
|
Estrone | 1 | 2020 | 232 | 0.160 |
Why?
|
Pregnancy Complications, Cardiovascular | 2 | 2016 | 516 | 0.160 |
Why?
|
Regression Analysis | 5 | 2019 | 6361 | 0.160 |
Why?
|
Amine Oxidase (Copper-Containing) | 1 | 2018 | 41 | 0.160 |
Why?
|
Angiogenic Proteins | 1 | 2018 | 101 | 0.160 |
Why?
|
Predictive Value of Tests | 7 | 2022 | 15273 | 0.150 |
Why?
|
Preconception Care | 1 | 2019 | 139 | 0.150 |
Why?
|
Carbanilides | 1 | 2018 | 18 | 0.150 |
Why?
|
Reference Values | 7 | 2018 | 4920 | 0.150 |
Why?
|
Retrospective Studies | 17 | 2023 | 80301 | 0.150 |
Why?
|
Isotretinoin | 1 | 2019 | 131 | 0.150 |
Why?
|
Esters | 3 | 2024 | 211 | 0.150 |
Why?
|
Benzophenones | 1 | 2018 | 58 | 0.150 |
Why?
|
Analgesia, Obstetrical | 1 | 2019 | 169 | 0.150 |
Why?
|
Prolactin | 1 | 2020 | 621 | 0.150 |
Why?
|
Infant, Very Low Birth Weight | 2 | 2016 | 406 | 0.150 |
Why?
|
Labor Stage, Second | 1 | 2017 | 37 | 0.150 |
Why?
|
Labor Presentation | 1 | 2017 | 55 | 0.150 |
Why?
|
Brain Diseases | 2 | 2003 | 1540 | 0.140 |
Why?
|
Thyroid Function Tests | 1 | 2018 | 290 | 0.140 |
Why?
|
Magnesium | 1 | 2020 | 810 | 0.140 |
Why?
|
Longitudinal Studies | 10 | 2020 | 14482 | 0.140 |
Why?
|
Massachusetts | 8 | 2023 | 8805 | 0.140 |
Why?
|
Body Size | 1 | 2019 | 462 | 0.140 |
Why?
|
Cross-Sectional Studies | 9 | 2021 | 25928 | 0.140 |
Why?
|
Risk Assessment | 10 | 2019 | 24086 | 0.130 |
Why?
|
Tretinoin | 1 | 2019 | 519 | 0.130 |
Why?
|
Adolescent | 19 | 2023 | 87747 | 0.130 |
Why?
|
Antioxidants | 1 | 2024 | 1668 | 0.130 |
Why?
|
Likelihood Functions | 1 | 2019 | 988 | 0.130 |
Why?
|
Suture Techniques | 1 | 2000 | 788 | 0.130 |
Why?
|
Fatty Acids | 1 | 2023 | 1805 | 0.130 |
Why?
|
Insurance Claim Review | 2 | 2018 | 737 | 0.130 |
Why?
|
Incidence | 11 | 2020 | 21378 | 0.130 |
Why?
|
Lead | 1 | 2021 | 880 | 0.120 |
Why?
|
Area Under Curve | 1 | 2019 | 1635 | 0.120 |
Why?
|
Live Birth | 1 | 2019 | 512 | 0.120 |
Why?
|
Socioeconomic Factors | 6 | 2019 | 7803 | 0.120 |
Why?
|
Infant | 15 | 2024 | 36030 | 0.120 |
Why?
|
Asymptomatic Diseases | 1 | 2018 | 582 | 0.120 |
Why?
|
Product Surveillance, Postmarketing | 1 | 2019 | 450 | 0.120 |
Why?
|
Proteomics | 2 | 2020 | 3810 | 0.120 |
Why?
|
Mongolia | 3 | 2020 | 93 | 0.120 |
Why?
|
Healthcare Disparities | 1 | 2010 | 3381 | 0.120 |
Why?
|
Risk | 4 | 2017 | 9629 | 0.120 |
Why?
|
Follow-Up Studies | 7 | 2019 | 39254 | 0.120 |
Why?
|
Infectious Disease Transmission, Vertical | 1 | 2021 | 1349 | 0.120 |
Why?
|
Demography | 1 | 2019 | 1650 | 0.120 |
Why?
|
Calcium-Binding Proteins | 1 | 2019 | 1066 | 0.110 |
Why?
|
Blood Chemical Analysis | 1 | 2016 | 437 | 0.110 |
Why?
|
Chorionic Gonadotropin, beta Subunit, Human | 1 | 2014 | 81 | 0.110 |
Why?
|
Hazardous Substances | 1 | 2015 | 152 | 0.110 |
Why?
|
Interleukin-1beta | 1 | 2019 | 999 | 0.110 |
Why?
|
Breast Feeding | 1 | 2022 | 1356 | 0.110 |
Why?
|
Antihypertensive Agents | 1 | 2023 | 2063 | 0.110 |
Why?
|
Blood Pressure | 3 | 2018 | 8523 | 0.110 |
Why?
|
Prenatal Diagnosis | 3 | 2023 | 1262 | 0.110 |
Why?
|
Thyrotropin | 1 | 2017 | 832 | 0.110 |
Why?
|
Lung | 2 | 2004 | 9989 | 0.110 |
Why?
|
Retinopathy of Prematurity | 2 | 2013 | 432 | 0.110 |
Why?
|
Coitus | 1 | 2014 | 131 | 0.110 |
Why?
|
Immunologic Factors | 1 | 2022 | 1589 | 0.110 |
Why?
|
Uterine Neoplasms | 1 | 2022 | 1434 | 0.100 |
Why?
|
Time Factors | 6 | 2019 | 40133 | 0.100 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2024 | 4357 | 0.100 |
Why?
|
HELLP Syndrome | 1 | 2012 | 40 | 0.100 |
Why?
|
Genomic Imprinting | 1 | 2014 | 330 | 0.100 |
Why?
|
Brain Injury, Chronic | 1 | 2012 | 68 | 0.100 |
Why?
|
Estrogens | 1 | 2019 | 1520 | 0.100 |
Why?
|
Fever | 1 | 2019 | 1618 | 0.100 |
Why?
|
Immunization | 1 | 2016 | 1228 | 0.100 |
Why?
|
Smoking | 4 | 2015 | 9070 | 0.100 |
Why?
|
Respiratory Sounds | 1 | 2016 | 697 | 0.100 |
Why?
|
Organ Size | 1 | 2016 | 2249 | 0.090 |
Why?
|
Cholecalciferol | 1 | 2016 | 546 | 0.090 |
Why?
|
Hyperoxia | 1 | 2013 | 250 | 0.090 |
Why?
|
Propensity Score | 1 | 2018 | 1918 | 0.090 |
Why?
|
Proportional Hazards Models | 3 | 2019 | 12532 | 0.090 |
Why?
|
Abortion, Habitual | 1 | 2010 | 62 | 0.090 |
Why?
|
Decidua | 2 | 2022 | 82 | 0.090 |
Why?
|
Heart Rate, Fetal | 1 | 2010 | 75 | 0.090 |
Why?
|
Folic Acid | 3 | 2023 | 1309 | 0.080 |
Why?
|
Air Pollution | 1 | 2023 | 2316 | 0.080 |
Why?
|
Child Behavior Disorders | 1 | 2014 | 805 | 0.080 |
Why?
|
Particulate Matter | 1 | 2021 | 2558 | 0.080 |
Why?
|
Postnatal Care | 2 | 2014 | 260 | 0.080 |
Why?
|
Probability | 2 | 2022 | 2476 | 0.080 |
Why?
|
Reproductive History | 1 | 2010 | 210 | 0.080 |
Why?
|
Bayes Theorem | 3 | 2023 | 2325 | 0.080 |
Why?
|
C-Reactive Protein | 3 | 2016 | 3822 | 0.080 |
Why?
|
Mental Recall | 1 | 2015 | 1205 | 0.080 |
Why?
|
Cephalometry | 1 | 2010 | 382 | 0.080 |
Why?
|
Urban Population | 1 | 2016 | 2021 | 0.080 |
Why?
|
Puerto Rico | 2 | 2019 | 373 | 0.080 |
Why?
|
Fetal Diseases | 1 | 2013 | 911 | 0.080 |
Why?
|
Diabetes Mellitus, Type 1 | 2 | 2020 | 3451 | 0.070 |
Why?
|
Attitude of Health Personnel | 1 | 2002 | 3870 | 0.070 |
Why?
|
Vaccines | 1 | 2016 | 833 | 0.070 |
Why?
|
Genetic Predisposition to Disease | 2 | 2020 | 17766 | 0.070 |
Why?
|
Gonadal Steroid Hormones | 1 | 2011 | 701 | 0.070 |
Why?
|
Labor, Obstetric | 2 | 2017 | 321 | 0.070 |
Why?
|
Child Development | 3 | 2022 | 2280 | 0.070 |
Why?
|
Statistics, Nonparametric | 1 | 2013 | 2852 | 0.070 |
Why?
|
Analysis of Variance | 1 | 2016 | 6242 | 0.070 |
Why?
|
Air Pollutants | 1 | 2021 | 2843 | 0.070 |
Why?
|
Parturition | 2 | 2023 | 445 | 0.070 |
Why?
|
Angiotensin II | 1 | 2010 | 850 | 0.070 |
Why?
|
Fertilization in Vitro | 1 | 2015 | 1292 | 0.070 |
Why?
|
Cerebral Ventricles | 1 | 2009 | 543 | 0.070 |
Why?
|
Sleep Deprivation | 1 | 2014 | 840 | 0.070 |
Why?
|
Comorbidity | 3 | 2021 | 10552 | 0.070 |
Why?
|
Maternal-Child Health Centers | 1 | 2006 | 42 | 0.070 |
Why?
|
Body Weight | 1 | 2017 | 4613 | 0.070 |
Why?
|
Hemostasis, Surgical | 1 | 2007 | 129 | 0.070 |
Why?
|
Uterus | 2 | 2018 | 651 | 0.070 |
Why?
|
Middle Aged | 12 | 2019 | 220175 | 0.070 |
Why?
|
Immunosuppressive Agents | 1 | 2019 | 4168 | 0.070 |
Why?
|
Rural Population | 1 | 2016 | 2267 | 0.070 |
Why?
|
Bacteremia | 1 | 2013 | 979 | 0.070 |
Why?
|
Triiodothyronine | 2 | 2018 | 493 | 0.060 |
Why?
|
Morbidity | 2 | 2021 | 1765 | 0.060 |
Why?
|
Sulfones | 2 | 2018 | 447 | 0.060 |
Why?
|
Phenotype | 2 | 2020 | 16543 | 0.060 |
Why?
|
Receptors, Cell Surface | 1 | 2014 | 2825 | 0.060 |
Why?
|
Malpractice | 1 | 2010 | 556 | 0.060 |
Why?
|
Steroids | 2 | 2018 | 928 | 0.060 |
Why?
|
Factor V | 1 | 2005 | 168 | 0.060 |
Why?
|
Diethylhexyl Phthalate | 2 | 2016 | 83 | 0.060 |
Why?
|
Treatment Outcome | 5 | 2023 | 64947 | 0.060 |
Why?
|
Isoprostanes | 1 | 2024 | 19 | 0.060 |
Why?
|
DNA | 1 | 2018 | 7236 | 0.060 |
Why?
|
Cluster Analysis | 1 | 2011 | 2698 | 0.060 |
Why?
|
Stress, Psychological | 1 | 2019 | 4440 | 0.060 |
Why?
|
Antigens, CD | 1 | 2014 | 4002 | 0.060 |
Why?
|
Blood Vessels | 1 | 2010 | 1112 | 0.060 |
Why?
|
Polypyrimidine Tract-Binding Protein | 1 | 2023 | 22 | 0.060 |
Why?
|
Biomedical Research | 1 | 2019 | 3421 | 0.060 |
Why?
|
Pregnancy Complications, Hematologic | 1 | 2005 | 177 | 0.060 |
Why?
|
Gene Expression Profiling | 1 | 2020 | 9388 | 0.060 |
Why?
|
Fluorescence Polarization | 1 | 2004 | 140 | 0.060 |
Why?
|
Infant, Low Birth Weight | 1 | 2008 | 858 | 0.060 |
Why?
|
Computational Biology | 1 | 2016 | 3504 | 0.060 |
Why?
|
Administration, Intravaginal | 1 | 2023 | 151 | 0.060 |
Why?
|
Research Design | 1 | 2019 | 6181 | 0.060 |
Why?
|
Ultrasonography | 2 | 2009 | 5960 | 0.060 |
Why?
|
Leptin | 1 | 2011 | 1590 | 0.050 |
Why?
|
Anesthesia, Obstetrical | 1 | 2005 | 233 | 0.050 |
Why?
|
Severity of Illness Index | 3 | 2021 | 15827 | 0.050 |
Why?
|
Developmental Disabilities | 1 | 2012 | 1504 | 0.050 |
Why?
|
Prognosis | 3 | 2021 | 29636 | 0.050 |
Why?
|
Practice Guidelines as Topic | 3 | 2016 | 7468 | 0.050 |
Why?
|
Feeding Behavior | 2 | 2014 | 3185 | 0.050 |
Why?
|
Genome-Wide Association Study | 2 | 2020 | 12602 | 0.050 |
Why?
|
Europe | 2 | 2020 | 3433 | 0.050 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2020 | 15766 | 0.050 |
Why?
|
Fetal Weight | 1 | 2022 | 87 | 0.050 |
Why?
|
Arachidonic Acid | 1 | 2024 | 434 | 0.050 |
Why?
|
Models, Biological | 1 | 2018 | 9468 | 0.050 |
Why?
|
Double-Blind Method | 3 | 2024 | 12412 | 0.050 |
Why?
|
Breast Neoplasms | 2 | 2020 | 21065 | 0.050 |
Why?
|
Progestins | 1 | 2023 | 303 | 0.050 |
Why?
|
Beta Particles | 1 | 2021 | 47 | 0.050 |
Why?
|
Nutritional Status | 2 | 2019 | 1606 | 0.050 |
Why?
|
Limit of Detection | 1 | 2022 | 280 | 0.050 |
Why?
|
Fatty Acids, Unsaturated | 1 | 2024 | 542 | 0.050 |
Why?
|
Algorithms | 2 | 2016 | 13967 | 0.040 |
Why?
|
Point Mutation | 1 | 2005 | 1594 | 0.040 |
Why?
|
Prevalence | 4 | 2019 | 15687 | 0.040 |
Why?
|
Hospitalization | 2 | 2021 | 10761 | 0.040 |
Why?
|
Extraction, Obstetrical | 1 | 2020 | 28 | 0.040 |
Why?
|
Sphingomyelins | 1 | 2000 | 103 | 0.040 |
Why?
|
Lactation | 1 | 2022 | 395 | 0.040 |
Why?
|
Insulin Resistance | 2 | 2016 | 3960 | 0.040 |
Why?
|
Phosphates | 1 | 2023 | 771 | 0.040 |
Why?
|
Radiography, Interventional | 1 | 2007 | 1112 | 0.040 |
Why?
|
Guidelines as Topic | 2 | 2016 | 1395 | 0.040 |
Why?
|
Pilot Projects | 3 | 2021 | 8553 | 0.040 |
Why?
|
Nervous System Diseases | 1 | 2010 | 1647 | 0.040 |
Why?
|
Vasculitis | 1 | 2003 | 523 | 0.040 |
Why?
|
Child, Preschool | 7 | 2019 | 42034 | 0.040 |
Why?
|
MicroRNAs | 1 | 2015 | 3784 | 0.040 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 1 | 2014 | 3695 | 0.040 |
Why?
|
Nerve Block | 1 | 2005 | 686 | 0.040 |
Why?
|
Pregnancy, Unplanned | 1 | 2019 | 87 | 0.040 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2013 | 2421 | 0.040 |
Why?
|
Maternal Mortality | 1 | 2021 | 300 | 0.040 |
Why?
|
Nutritional Requirements | 1 | 2000 | 275 | 0.040 |
Why?
|
Pregnancy in Adolescence | 1 | 2000 | 162 | 0.040 |
Why?
|
Phosphatidylcholines | 1 | 2000 | 406 | 0.040 |
Why?
|
Tetanus | 1 | 1998 | 51 | 0.040 |
Why?
|
Oxygen | 1 | 2010 | 4189 | 0.040 |
Why?
|
Diseases in Twins | 1 | 2000 | 447 | 0.040 |
Why?
|
Glycogen | 1 | 2018 | 251 | 0.040 |
Why?
|
Michigan | 1 | 2019 | 342 | 0.040 |
Why?
|
Naphthalenesulfonates | 1 | 2017 | 15 | 0.040 |
Why?
|
Registries | 3 | 2019 | 8449 | 0.040 |
Why?
|
Tetanus Toxoid | 1 | 1998 | 193 | 0.040 |
Why?
|
Immunity, Maternally-Acquired | 1 | 1998 | 111 | 0.040 |
Why?
|
Lipid Peroxidation | 1 | 2018 | 271 | 0.040 |
Why?
|
Cognition Disorders | 1 | 2012 | 3976 | 0.040 |
Why?
|
Intracranial Hemorrhages | 1 | 2003 | 844 | 0.040 |
Why?
|
Triclosan | 1 | 2018 | 58 | 0.040 |
Why?
|
California | 1 | 2021 | 1416 | 0.040 |
Why?
|
Substance-Related Disorders | 1 | 2014 | 4370 | 0.040 |
Why?
|
Norway | 1 | 2018 | 497 | 0.040 |
Why?
|
Matrix Metalloproteinase 1 | 1 | 2017 | 142 | 0.040 |
Why?
|
Receptors, Vascular Endothelial Growth Factor | 2 | 2011 | 666 | 0.040 |
Why?
|
Anti-HIV Agents | 1 | 2013 | 4492 | 0.040 |
Why?
|
Interferon-beta | 1 | 2019 | 345 | 0.040 |
Why?
|
Cardiovascular Diseases | 2 | 2015 | 15740 | 0.030 |
Why?
|
Enterocolitis, Necrotizing | 1 | 2001 | 326 | 0.030 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2021 | 2509 | 0.030 |
Why?
|
Data Interpretation, Statistical | 2 | 2018 | 2696 | 0.030 |
Why?
|
Israel | 1 | 2019 | 722 | 0.030 |
Why?
|
Genotype | 2 | 2023 | 12959 | 0.030 |
Why?
|
Lactic Acid | 1 | 2021 | 1132 | 0.030 |
Why?
|
Patient Compliance | 1 | 2006 | 2689 | 0.030 |
Why?
|
Pregnancy Rate | 1 | 2019 | 650 | 0.030 |
Why?
|
Cleft Lip | 1 | 2001 | 504 | 0.030 |
Why?
|
Minority Groups | 1 | 2023 | 1199 | 0.030 |
Why?
|
Telomere | 1 | 2022 | 934 | 0.030 |
Why?
|
Nitrogen Dioxide | 1 | 2019 | 512 | 0.030 |
Why?
|
Diabetes Mellitus | 1 | 2014 | 5884 | 0.030 |
Why?
|
Child | 6 | 2022 | 79758 | 0.030 |
Why?
|
Parents | 2 | 2023 | 3547 | 0.030 |
Why?
|
HIV-1 | 1 | 2013 | 6850 | 0.030 |
Why?
|
False Negative Reactions | 1 | 2016 | 574 | 0.030 |
Why?
|
DNA Methylation | 2 | 2023 | 4374 | 0.030 |
Why?
|
Membrane Proteins | 1 | 2012 | 7854 | 0.030 |
Why?
|
Aspartic Acid | 1 | 2017 | 576 | 0.030 |
Why?
|
Research Support as Topic | 1 | 2019 | 699 | 0.030 |
Why?
|
Carbon | 1 | 2018 | 669 | 0.030 |
Why?
|
Recurrence | 2 | 2019 | 8487 | 0.030 |
Why?
|
Neurotransmitter Agents | 1 | 2018 | 661 | 0.030 |
Why?
|
Blood Transfusion | 1 | 2021 | 1328 | 0.030 |
Why?
|
Nuclear Family | 1 | 2015 | 313 | 0.030 |
Why?
|
Databases, Factual | 3 | 2019 | 8018 | 0.030 |
Why?
|
Matrix Metalloproteinase 9 | 1 | 2017 | 633 | 0.030 |
Why?
|
Metabolic Networks and Pathways | 1 | 2018 | 788 | 0.030 |
Why?
|
False Positive Reactions | 1 | 2016 | 956 | 0.030 |
Why?
|
Hormones | 1 | 2018 | 867 | 0.030 |
Why?
|
Veins | 1 | 2018 | 765 | 0.030 |
Why?
|
Lymphatic Vessels | 1 | 2018 | 358 | 0.030 |
Why?
|
Heart Defects, Congenital | 1 | 2010 | 4668 | 0.030 |
Why?
|
Pregnancy, High-Risk | 1 | 2014 | 119 | 0.030 |
Why?
|
Fluid Therapy | 1 | 2017 | 593 | 0.030 |
Why?
|
Seasons | 1 | 2019 | 1523 | 0.030 |
Why?
|
Calibration | 1 | 2016 | 816 | 0.030 |
Why?
|
Arteries | 1 | 2018 | 1126 | 0.030 |
Why?
|
Reproducibility of Results | 3 | 2016 | 20048 | 0.030 |
Why?
|
Infertility | 1 | 2019 | 655 | 0.030 |
Why?
|
Point-of-Care Systems | 1 | 2021 | 1208 | 0.030 |
Why?
|
Adverse Drug Reaction Reporting Systems | 1 | 2016 | 488 | 0.030 |
Why?
|
Killer Cells, Natural | 1 | 2022 | 2204 | 0.030 |
Why?
|
Sweden | 1 | 2015 | 1381 | 0.030 |
Why?
|
Diabetes Complications | 1 | 2019 | 1342 | 0.030 |
Why?
|
Adiposity | 1 | 2022 | 1851 | 0.030 |
Why?
|
Pyrroles | 1 | 2017 | 1137 | 0.020 |
Why?
|
Adrenal Cortex Hormones | 1 | 2000 | 1870 | 0.020 |
Why?
|
Fetal Monitoring | 1 | 2010 | 69 | 0.020 |
Why?
|
Corticotropin-Releasing Hormone | 1 | 2011 | 361 | 0.020 |
Why?
|
Spectrometry, Mass, Electrospray Ionization | 1 | 2011 | 267 | 0.020 |
Why?
|
Age Factors | 2 | 2019 | 18415 | 0.020 |
Why?
|
Botswana | 1 | 2013 | 1042 | 0.020 |
Why?
|
Drug Prescriptions | 1 | 2019 | 1673 | 0.020 |
Why?
|
Receptors, Cytokine | 1 | 2010 | 258 | 0.020 |
Why?
|
Observer Variation | 1 | 2016 | 2596 | 0.020 |
Why?
|
Vascular Endothelial Growth Factor A | 2 | 2011 | 3483 | 0.020 |
Why?
|
Acute-Phase Proteins | 1 | 2010 | 250 | 0.020 |
Why?
|
Mice, Knockout | 2 | 2018 | 14396 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2019 | 6499 | 0.020 |
Why?
|
Metabolomics | 1 | 2018 | 1626 | 0.020 |
Why?
|
Sepsis | 1 | 2003 | 2594 | 0.020 |
Why?
|
Adrenal Glands | 1 | 2011 | 556 | 0.020 |
Why?
|
Cardiovascular Surgical Procedures | 1 | 2010 | 192 | 0.020 |
Why?
|
Overweight | 1 | 2020 | 2421 | 0.020 |
Why?
|
Computer Simulation | 1 | 2022 | 6210 | 0.020 |
Why?
|
Lipids | 1 | 2019 | 3336 | 0.020 |
Why?
|
Diet, Sodium-Restricted | 1 | 2010 | 291 | 0.020 |
Why?
|
Survival Analysis | 1 | 2001 | 10185 | 0.020 |
Why?
|
Patient Readmission | 1 | 2022 | 3327 | 0.020 |
Why?
|
Catechol O-Methyltransferase | 1 | 2010 | 251 | 0.020 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 1 | 2014 | 1988 | 0.020 |
Why?
|
Cross-Over Studies | 1 | 2014 | 2061 | 0.020 |
Why?
|
Systole | 1 | 2010 | 947 | 0.020 |
Why?
|
Aspirin | 1 | 2020 | 3365 | 0.020 |
Why?
|
Peroxidase | 1 | 2010 | 604 | 0.020 |
Why?
|
Cell Hypoxia | 1 | 2010 | 657 | 0.020 |
Why?
|
Hospitals | 1 | 2021 | 3929 | 0.020 |
Why?
|
Data Collection | 1 | 2016 | 3317 | 0.020 |
Why?
|
HIV Infections | 1 | 2013 | 17159 | 0.020 |
Why?
|
Multicenter Studies as Topic | 1 | 2011 | 1723 | 0.020 |
Why?
|
Mice | 3 | 2022 | 81216 | 0.020 |
Why?
|
Confidence Intervals | 1 | 2012 | 2932 | 0.020 |
Why?
|
Sodium, Dietary | 1 | 2010 | 425 | 0.020 |
Why?
|
Alcohol Drinking | 1 | 2019 | 4012 | 0.020 |
Why?
|
Secondary Prevention | 1 | 2012 | 1548 | 0.020 |
Why?
|
Drug Synergism | 1 | 2010 | 1755 | 0.020 |
Why?
|
Milk, Human | 1 | 2010 | 484 | 0.020 |
Why?
|
Developing Countries | 1 | 1998 | 2880 | 0.020 |
Why?
|
Infusions, Intravenous | 1 | 2010 | 2235 | 0.020 |
Why?
|
Homeostasis | 1 | 2016 | 3305 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2016 | 5201 | 0.020 |
Why?
|
Sodium | 1 | 2010 | 1601 | 0.010 |
Why?
|
Antiretroviral Therapy, Highly Active | 1 | 2013 | 1894 | 0.010 |
Why?
|
Vesicovaginal Fistula | 1 | 1964 | 9 | 0.010 |
Why?
|
Viral Load | 1 | 2013 | 3323 | 0.010 |
Why?
|
Postpartum Hemorrhage | 1 | 2007 | 265 | 0.010 |
Why?
|
Cell Adhesion | 1 | 2010 | 3096 | 0.010 |
Why?
|
Urinary Bladder Diseases | 1 | 1964 | 169 | 0.010 |
Why?
|
Alleles | 1 | 2014 | 6900 | 0.010 |
Why?
|
Catheterization | 1 | 2007 | 1432 | 0.010 |
Why?
|
Animals | 3 | 2022 | 167940 | 0.010 |
Why?
|
Pandemics | 1 | 2021 | 8621 | 0.010 |
Why?
|
Clinical Competence | 1 | 2016 | 4786 | 0.010 |
Why?
|
Iatrogenic Disease | 1 | 1964 | 538 | 0.010 |
Why?
|
Obstetrical Forceps | 1 | 1999 | 8 | 0.010 |
Why?
|
Liver | 1 | 2016 | 7512 | 0.010 |
Why?
|
Vacuum Extraction, Obstetrical | 1 | 1999 | 14 | 0.010 |
Why?
|
Health Care Surveys | 1 | 2006 | 2434 | 0.010 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2010 | 3601 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2018 | 18134 | 0.010 |
Why?
|
Wounds and Injuries | 2 | 1999 | 2477 | 0.010 |
Why?
|
Physicians | 1 | 2016 | 4590 | 0.010 |
Why?
|
Labor, Induced | 1 | 1999 | 151 | 0.010 |
Why?
|
Heparin | 1 | 2005 | 1655 | 0.010 |
Why?
|
Cell Movement | 1 | 2010 | 5206 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2015 | 11902 | 0.010 |
Why?
|
Immunization Schedule | 1 | 1998 | 225 | 0.010 |
Why?
|
Congenital Abnormalities | 1 | 2001 | 704 | 0.010 |
Why?
|
Venous Thrombosis | 1 | 2005 | 1293 | 0.010 |
Why?
|
Bangladesh | 1 | 1998 | 734 | 0.010 |
Why?
|
Injury Severity Score | 1 | 1999 | 1035 | 0.010 |
Why?
|
Oxytocin | 1 | 1999 | 401 | 0.010 |
Why?
|
Immunization Programs | 1 | 1998 | 268 | 0.010 |
Why?
|
Poverty | 1 | 2006 | 2695 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2010 | 18968 | 0.010 |
Why?
|
Brain | 1 | 2020 | 26912 | 0.010 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2016 | 12281 | 0.010 |
Why?
|
Health Services Accessibility | 1 | 2006 | 5396 | 0.010 |
Why?
|
Cause of Death | 1 | 1998 | 3723 | 0.000 |
Why?
|
Magnetic Resonance Imaging | 1 | 2013 | 36247 | 0.000 |
Why?
|
Survival Rate | 1 | 1998 | 12806 | 0.000 |
Why?
|
Postoperative Complications | 1 | 1964 | 15680 | 0.000 |
Why?
|